Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

SottoPelle® Expands Availability of Training Programs to Qualified Doctors

Increased patient demand for natural hormone therapy drives growth of national physician training program

SottoPelle(R) Therapy is based on achieving physiologic hormonal balance, something research has shown is absolutely vital to one's good health and well-being. Developed by Gino Tutera MD, FACOG, an internationally recognized pioneer and leader in the field of bio-identical hormone replacement therapy. He has pioneered SottoPelle(R), a remarkable method of natural hormone therapy based on a proprietary bio-identical pellet hormone delivery system (BioCalc). (PRNewsFoto/SottoPelle Therapy) (PRNewsFoto/SottoPelle Therapy)

News provided by

SottoPelle

Oct 13, 2014, 05:00 ET

Share this article

Share toX

Share this article

Share toX

SCOTTSDALE, Ariz., Oct. 13, 2014 /PRNewswire/ -- As Baby Boomers continue to face aging and deteriorating health, the demand for Bio-Identical Hormone Therapy (BHRT) via safe and natural methods continues to grow. As the interest in BHRT spreads across this demographic, the medical field is quickly ramping up on appropriate training to treat patients. 

Continue Reading
Dr. Gino Tutera - SottoPelle Therapy,  http://www.sottopelletherapy.com/gino-tutera-md/ (PRNewsFoto/SottoPelle Therapy) (PRNewsFoto/SottoPelle Therapy)
Dr. Gino Tutera - SottoPelle Therapy, http://www.sottopelletherapy.com/gino-tutera-md/ (PRNewsFoto/SottoPelle Therapy) (PRNewsFoto/SottoPelle Therapy)
Dr. James Mirabile - SottoPelle Therapy,  http://www.sottopelletherapy.com/doctors/james-mirabile-md-facog/ (PRNewsFoto/SottoPelle Therapy) (PRNewsFoto/SottoPelle Therapy)
Dr. James Mirabile - SottoPelle Therapy, http://www.sottopelletherapy.com/doctors/james-mirabile-md-facog/ (PRNewsFoto/SottoPelle Therapy) (PRNewsFoto/SottoPelle Therapy)
Dr. Kenneth Sekine - SottoPelle Therapy,  http://www.sottopelletherapy.com/doctors/kenneth-sekine-md/ (PRNewsFoto/SottoPelle Therapy) (PRNewsFoto/SottoPelle Therapy)
Dr. Kenneth Sekine - SottoPelle Therapy, http://www.sottopelletherapy.com/doctors/kenneth-sekine-md/ (PRNewsFoto/SottoPelle Therapy) (PRNewsFoto/SottoPelle Therapy)

SottoPelle® Founder and Medical Director Dr. Gino Tutera, M.D., F.A.C.O.G., and his qualified team provide physician education and expert training in his proprietary, patent-pending, Web-based BioCalc® system of natural bio-identical hormone pellet therapy, which provides precision dosing individualized for each patient for optimal health, hormonal balance and disease prevention.

SottoPelle® is an international medical company and respected hormone therapy leader based in Scottsdale, Ariz., with nearly 200 affiliate doctors in the United States. The BioCalc® method was developed over 23 years ago by Dr. Tutera, who is a board-certified obstetrician and gynecologist with 40 years of clinical experience and widely recognized as a pioneer in hormone therapy.

The success of this treatment has led to the recent expansion of SottoPelle®'s Tutera Institute, with an ongoing series of physician trainings at three new centers across the country. The goal is to extend the availability of its highly specialized medical training to better serve doctors interested in learning SottoPelle®'s hormone pellet therapy for men and women. The Tutera Institute now provides the following schedule of additional training sessions to educate doctors in the BioCalc® method, with the support of two additional physicians:

  1. Scottsdale, Ariz., at SottoPelle®  headquarters with Dr. Tutera; Mondays Oct. 6, Nov. 3 and Dec. 8  
  2. Jacksonville, Fla., with Dr. Kenneth Sekine, M.D., F.A.C.O.G., of North Florida Hormone Therapy (www.northfloridahormonetherapy.com); Saturdays October 18 and November 15
  3. Kansas City, Mo., with Dr. James Mirabile, M.D., F.A.C.O.G., of Mirabile MD Beauty, Health & Wellness (www.mirabilemd.com);  Saturdays October 25 and November 22

Drs. Sekine and Mirabile are board-certified obstetricians and gynecologists with 55 years of combined experience and who have been trained by Dr. Tutera in BioCalc® dosing. They were recently appointed to the SottoPelle® Advisory Board, a newly-named team comprised of outstanding medical and business professionals who offer vast expertise in their respective fields (http://www.sottopelletherapy.com/advisory-board). The board's mission is to advance awareness and bring the importance of quality precision-dosed bio-identical hormone pellet therapy to mainstream America.

"Our physicians receive invaluable insight and training that is the product of my two decades of experience with thousands of patients," stated Dr. Tutera. "Anyone can place pellets and you will find many who will try, but nobody understands your body with pellets like the experts at SottoPelle®, as we have this medical science down to an art form."

Doctors can enroll in the trainings and obtain more information at http://doctors.sottopelletherapy.com. All of SottoPelle®'s existing affiliate physicians are encouraged to attend these sessions for further development and updates on the best practices and medical research in Age Management Medicine.

"Learning firsthand with Dr. Tutera has been an unparalleled experience," said Dr. Mirabile. "It has increased my knowledge about both women and men's health and the phenomenal benefits they receive from SottoPelle® pellets. The training of new physicians around the country and participating with continuing education of the present SottoPelle® physicians is very rewarding. I am actively helping other practitioners administer the therapies that benefit their patients and improve their lives."

"Now physicians from across the country will have the opportunity to learn about SottoPelle at our practice in Jacksonville, Florida," stated Dr. Sekine, founder of North Florida Hormone Therapy, an approved SottoPelle training physician. "We are pleased to know that SottoPelle patients from across the country will now be able to attain a steady low dose of natural hormones and control the release of the hormones, just as when their ovaries and testicles were working normally."

"North Florida Hormone Therapy is honored to be chosen as the training facility for SottoPelle and East Coast physicians," Dr Sekine said. "Our staff is highly trained and knowledgeable in the renowned SottoPelle method and our patients appreciate the outstanding results of hormone pellet therapy. We treat our patients with balanced hormones to live healthy lives and to alleviate their hormone level decline and imbalance along with a multitude of distressing symptoms."

What is SottoPelle® and BioCalc ®? 

Developed by Dr. Gino Tutera, M.D., F.A.C.O.G., more than two decades ago, SottoPelle® is an evidence-based proprietary method of BHRT. It differs from traditional Hormone Replacement Therapy (HRT) by offering a precise, Web-based, individualized dosage delivery system (BioCalc®) prescribed for each patient's specific medical needs. It is administered subcutaneously through natural pellets whose molecular structure mimics the body's natural hormones. The treatment uses the highest quality plant-based pellets and SottoPelle®'s patent-pending BioCalc® dosing application via a unique insertion technique to generate steady and consistent serum levels for patients. Unlike many of today's synthetic hormones with one-size-fits-all generic doses, SottoPelle® delivers a consistent flow of natural hormones on a 24-7 basis to support better health.

For more information about SottoPelle® and BioCalc®, visit www.sottopelletherapy.com/.

Doctor bios and photos:

Dr. Tutera: http://www.sottopelletherapy.com/gino-tutera-md/

Dr. Mirabile: http://www.sottopelletherapy.com/doctors/james-mirabile-md-facog/

Dr. Sekine:  http://www.sottopelletherapy.com/doctors/kenneth-sekine-md/

SOTTOPELLE® MEDIA CONTACT:

Catherine J. Rourke 
Communications Director/Medical Journalist 
Phone: 480-682-4814, ext. 287 
Fax: 480-941-1518
Cell: 928-300-5568 
Email: [email protected]  

Logo - http://photos.prnewswire.com/prnh/20141008/151535LOGO

Photo - http://photos.prnewswire.com/prnh/20141008/151561  

Photo - http://photos.prnewswire.com/prnh/20141008/151517

Photo - http://photos.prnewswire.com/prnh/20141008/151518

SOURCE SottoPelle

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.